Change Language

Select Language

COVID-19
The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.

Immunohematology Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026

The global immunohematology market reached a value of US$ 2.1 Billion in 2020. Looking forward, IMARC Group expects the market to grow at a CAGR of around 6% during 2021-2026. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.

Immunohematology refers to a branch of medical sciences that studies blood and blood-forming tissues in relation to the immune system. It is used to study the presence of antigens in the blood and their reaction with antibodies that can either cause hemolysis or red blood cell (RBC) agglutination. Various immunohematology tests are conducted to ensure safe blood transfusion and prevent undesired immunity-, transplant-, and pregnancy-related reactions, and to diagnose blood related disorders and diseases such as HIV, Hepatitis, etc. They utilize various chemicals and devices, such as reagents, and automatic and semi-automatic analyzers that are based on the technology of microplates, biochips, gel cards, polymerase chain reaction and erythrocyte-magnetized technology (EMT).

The increasing prevalence of leukemia and other hematological disorders across the globe is one of the key factors driving the growth of the market. Furthermore, improvements in the healthcare infrastructure and the development of blood banks and trauma centers, especially in developing countries, is also providing a boost to the market growth. Increasing awareness among the masses regarding the activities associated with blood collection, processing, testing and storage has further created a positive impact on the demand for immunohematology devices. Additionally, various technological advancements, such as the development of innovative transfusion systems and fully-automated devices, are acting as other growth-inducing factors. These next-generation immunohematology devices aid in enhancing the efficacy of the diagnosis, minimizing analysis time and risk of human error, and providing emergency assistance to the patients. Other factors, including an increasing number of blood donation camps and awareness programs, along with improvements in the healthcare infrastructure, are projected to drive the market further. 

Breakup by Product:

  • Analyzing Systems
  • Reagents and Consumables
     

Breakup by Technology:

  • Biochips
  • Gel Cards
  • Microplates
  • Polymerase Chain Reaction
  • Erythrocyte-Magnetized Technology (EMT)
  • Others
     

Breakup by Application:

  • Blood-Related Disorders
  • HIV
  • Hepatitis
  • Blood Transfusion
  • Others
     

Breakup by End-User:

  • Hospitals
  • Blood Banks
  • Diagnostic Laboratories
  • Others
     

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa
     

Competitive Landscape:

The report has also analysed the competitive landscape of the market with some of the key players being Abbott, Antisel, BD (Becton Dickinson and Company), Beckman Coulter Inc. (Danaher Corporation), Bio-Rad Laboratories Inc., F. Hoffmann-La Roche Ltd., Grifols S.A., Merck KGaA, MTC Invitro Diagnostics AG, Ortho-Clinical Diagnostics Inc (The Carlyle Group), Siemens Healthcare GmbH, Thermo Fisher Scientific Inc., etc.

Report Coverages:

Report Features Details
Base Year of the Analysis 2020
Historical Period 2015-2020
Forecast Period 2021-2026
Units US$ Billion
Segment Coverage Product, Technology, Application, End-User, Region
Region Covered  Asia Pacific, Europe, North America, Latin America, Middle East and Africa
Countries Covered United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico
Companies Covered Abbott, Antisel, BD (Becton Dickinson and Company), Beckman Coulter Inc. (Danaher Corporation), Bio-Rad Laboratories Inc., F. Hoffmann-La Roche Ltd., Grifols S.A., Merck KGaA, MTC Invitro Diagnostics AG, Ortho-Clinical Diagnostics Inc (The Carlyle Group), Siemens Healthcare GmbH and Thermo Fisher Scientific Inc.
Customization Scope 10% Free Customization
Report Price and Purchase Option Single User License: US$ 2299
Five User License: US$ 3399
Corporate License: US$ 4499
Post-Sale Analyst Support 10-12 Weeks
Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

 

Key Questions Answered in This Report:

  • How has the global immunohematology market performed so far and how will it perform in the coming years?
  • What are the key regional markets?
  • What has been the impact of COVID-19 on the global immunohematology market?
  • What is the breakup of the market based on the product?
  • What is the breakup of the market based on the technology?
  • What is the breakup of the market based on the application?
  • What is the breakup of the market based on the end-user?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global immunohematology market and who are the key players?
  • What is the degree of competition in the industry?

1    Preface
2    Scope and Methodology 

    2.1    Objectives of the Study
    2.2    Stakeholders
    2.3    Data Sources
        2.3.1    Primary Sources
        2.3.2    Secondary Sources
    2.4    Market Estimation
        2.4.1    Bottom-Up Approach
        2.4.2    Top-Down Approach
    2.5    Forecasting Methodology
3    Executive Summary
4    Introduction

    4.1    Overview
    4.2    Key Industry Trends
5    Global Immunohematology Market
    5.1    Market Overview
    5.2    Market Performance
    5.3    Impact of COVID-19
    5.4    Market Forecast
6    Market Breakup by Product
    6.1    Analyzing Systems
        6.1.1 Market Trends
        6.1.2 Market Forecast
    6.2    Reagents and Consumables
        6.2.1 Market Trends
        6.2.2 Market Forecast
7    Market Breakup by Technology
    7.1    Biochips
        7.1.1 Market Trends
        7.1.2 Market Forecast
    7.2    Gel Cards
        7.2.1 Market Trends
        7.2.2 Market Forecast
    7.3    Microplates
        7.3.1 Market Trends
        7.3.2 Market Forecast
    7.4    Polymerase Chain Reaction
        7.4.1 Market Trends
        7.4.2 Market Forecast
    7.5    Erythrocyte-Magnetized Technology (EMT)
        7.5.1 Market Trends
        7.5.2 Market Forecast
    7.6    Others
        7.6.1 Market Trends
        7.6.2 Market Forecast
8    Market Breakup by Application
    8.1    Blood-Related Diseases
        8.1.1 Market Trends
        8.1.2 Market Forecast
    8.2    HIV
        8.2.1 Market Trends
        8.2.2 Market Forecast
    8.3    Hepatitis
        8.3.1 Market Trends
        8.3.2 Market Forecast
    8.4    Blood Transfusion
        8.4.1 Market Trends
        8.4.2 Market Forecast
    8.5    Others
        8.5.1 Market Trends
        8.5.2 Market Forecast
9    Market Breakup by End-User
    9.1    Hospitals
        9.1.1 Market Trends
        9.1.2 Market Forecast
    9.2    Blood Banks
        9.2.1 Market Trends
        9.2.2 Market Forecast
    9.3    Diagnostic Laboratories
        9.3.1 Market Trends
        9.3.2 Market Forecast
    9.4    Others
        9.4.1 Market Trends
        9.4.2 Market Forecast
10    Market Breakup by Region
    10.1    North America
        10.1.1 United States
           10.1.1.1 Market Trends
           10.1.1.2 Market Forecast
        10.1.2 Canada
           10.1.2.1 Market Trends
           10.1.2.2 Market Forecast
    10.2    Asia Pacific
        10.2.1 China
           10.2.1.1 Market Trends
           10.2.1.2 Market Forecast
        10.2.2 Japan
           10.2.2.1 Market Trends
           10.2.2.2 Market Forecast
        10.2.3 India
           10.2.3.1 Market Trends
           10.2.3.2 Market Forecast
        10.2.4 South Korea
           10.2.4.1 Market Trends
           10.2.4.2 Market Forecast
        10.2.5 Australia
           10.2.5.1 Market Trends
           10.2.5.2 Market Forecast
        10.2.6 Indonesia
           10.2.6.1 Market Trends
           10.2.6.2 Market Forecast
        10.2.7 Others
           10.2.7.1 Market Trends
           10.2.7.2 Market Forecast
    10.3    Europe
        10.3.1 Germany
           10.3.1.1 Market Trends
           10.3.1.2 Market Forecast
        10.3.2 France
           10.3.2.1 Market Trends
           10.3.2.2 Market Forecast
        10.3.3 United Kingdom
           10.3.3.1 Market Trends
           10.3.3.2 Market Forecast
        10.3.4 Italy
           10.3.4.1 Market Trends
           10.3.4.2 Market Forecast
        10.3.5 Spain
           10.3.5.1 Market Trends
           10.3.5.2 Market Forecast
        10.3.6 Russia
           10.3.6.1 Market Trends
           10.3.6.2 Market Forecast
        10.3.7 Others
           10.3.7.1 Market Trends
           10.3.7.2 Market Forecast
    10.4    Latin America
        10.4.1 Brazil
           10.4.1.1 Market Trends
           10.4.1.2 Market Forecast
        10.4.2 Mexico
           10.4.2.1 Market Trends
           10.4.2.2 Market Forecast
        10.4.3 Others
           10.4.3.1 Market Trends
           10.4.3.2 Market Forecast
    10.5    Middle East and Africa
        10.5.1 Market Trends
        10.5.2 Market Breakup by Country
        10.5.3 Market Forecast
11    SWOT Analysis
    11.1    Overview
    11.2    Strengths
    11.3    Weaknesses
    11.4    Opportunities
    11.5    Threats
12    Value Chain Analysis
13    Porters Five Forces Analysis

    13.1    Overview
    13.2    Bargaining Power of Buyers
    13.3    Bargaining Power of Suppliers
    13.4    Degree of Competition
    13.5    Threat of New Entrants
    13.6    Threat of Substitutes
14    Competitive Landscape
    14.1    Market Structure
    14.2    Key Players
    14.3    Profiles of Key Players
        14.3.1    Abbott
           14.3.1.1 Company Overview
           14.3.1.2 Product Portfolio 
           14.3.1.3 Financials 
           14.3.1.4 SWOT Analysis
        14.3.2    Antisel
           14.3.2.1 Company Overview
           14.3.2.2 Product Portfolio
        14.3.3    BD (Becton Dickinson and Company)
           14.3.3.1 Company Overview
           14.3.3.2 Product Portfolio 
           14.3.3.3 Financials 
           14.3.3.4 SWOT Analysis
        14.3.4    Beckman Coulter Inc. (Danaher Corporation)
           14.3.4.1 Company Overview
           14.3.4.2 Product Portfolio 
           14.3.4.3 SWOT Analysis
        14.3.5    Bio-Rad Laboratories Inc.
           14.3.5.1 Company Overview
           14.3.5.2 Product Portfolio 
           14.3.5.3 Financials 
           14.3.5.4 SWOT Analysis
        14.3.6    F. Hoffmann-La Roche Ltd.
           14.3.6.1 Company Overview
           14.3.6.2 Product Portfolio 
           14.3.6.3 SWOT Analysis
        14.3.7    Grifols S.A.
           14.3.7.1 Company Overview
           14.3.7.2 Product Portfolio
           14.3.7.3 Financials 
           14.3.7.4 SWOT Analysis
        14.3.8    Merck KGaA
           14.3.8.1 Company Overview
           14.3.8.2 Product Portfolio
           14.3.8.3 Financials 
           14.3.8.4 SWOT Analysis
        14.3.9    MTC Invitro Diagnostics AG
           14.3.9.1 Company Overview
           14.3.9.2 Product Portfolio 
           14.3.9.3 Financials 
        14.3.10    Ortho-Clinical Diagnostics Inc (The Carlyle Group)
           14.3.10.1 Company Overview
           14.3.10.2 Product Portfolio 
           14.3.10.3 SWOT Analysis
        14.3.11    Siemens Healthcare GmbH
           14.3.11.1 Company Overview
           14.3.11.2 Product Portfolio 
           14.3.11.3 Financials
           14.3.11.4 SWOT Analysis
        14.3.12    Thermo Fisher Scientific Inc.
           14.3.12.1 Company Overview
           14.3.12.2 Product Portfolio 
           14.3.12.3 Financials
           14.3.12.4 SWOT Analysis

List of Figures

Figure 1: Global: Immunohematology Market: Major Drivers and Challenges
Figure 2: Global: Immunohematology Market: Sales Value (in Billion US$), 2015-2020
Figure 3: Global: Immunohematology Market: Breakup by Product (in %), 2020
Figure 4: Global: Immunohematology Market: Breakup by Technology (in %), 2020
Figure 5: Global: Immunohematology Market: Breakup by Application (in %), 2020
Figure 6: Global: Immunohematology Market: Breakup by End-User (in %), 2020
Figure 7: Global: Immunohematology Market: Breakup by Region (in %), 2020
Figure 8: Global: Immunohematology Market Forecast: Sales Value (in Billion US$), 2021-2026
Figure 9: Global: Immunohematology (Analyzing Systems) Market: Sales Value (in Million US$), 2015 & 2020
Figure 10: Global: Immunohematology (Analyzing Systems) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 11: Global: Immunohematology (Reagents and Consumables) Market: Sales Value (in Million US$), 2015 & 2020
Figure 12: Global: Immunohematology (Reagents and Consumables) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 13: Global: Immunohematology (Biochips) Market: Sales Value (in Million US$), 2015 & 2020
Figure 14: Global: Immunohematology (Biochips) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 15: Global: Immunohematology (Gel Cards) Market: Sales Value (in Million US$), 2015 & 2020
Figure 16: Global: Immunohematology (Gel Cards) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 17: Global: Immunohematology (Microplates) Market: Sales Value (in Million US$), 2015 & 2020
Figure 18: Global: Immunohematology (Microplates) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 19: Global: Immunohematology (Polymerase Chain Reaction) Market: Sales Value (in Million US$), 2015 & 2020
Figure 20: Global: Immunohematology (Polymerase Chain Reaction) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 21: Global: Immunohematology (Erythrocyte-Magnetized Technology) Market: Sales Value (in Million US$), 2015 & 2020
Figure 22: Global: Immunohematology (Erythrocyte-Magnetized Technology) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 23: Global: Immunohematology (Other Technologies) Market: Sales Value (in Million US$), 2015 & 2020
Figure 24: Global: Immunohematology (Other Technologies) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 25: Global: Immunohematology (Blood-Related Diseases) Market: Sales Value (in Million US$), 2015 & 2020
Figure 26: Global: Immunohematology (Blood-Related Diseases) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 27: Global: Immunohematology (HIV) Market: Sales Value (in Million US$), 2015 & 2020
Figure 28: Global: Immunohematology (HIV) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 29: Global: Immunohematology (Hepatitis) Market: Sales Value (in Million US$), 2015 & 2020
Figure 30: Global: Immunohematology (Hepatitis) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 31: Global: Immunohematology (Blood Transfusion) Market: Sales Value (in Million US$), 2015 & 2020
Figure 32: Global: Immunohematology (Blood Transfusion) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 33: Global: Immunohematology (Others) Market: Sales Value (in Million US$), 2015 & 2020
Figure 34: Global: Immunohematology (Others) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 35: Global: Immunohematology (Hospitals) Market: Sales Value (in Million US$), 2015 & 2020
Figure 36: Global: Immunohematology (Hospitals) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 37: Global: Immunohematology (Blood Banks) Market: Sales Value (in Million US$), 2015 & 2020
Figure 38: Global: Immunohematology (Blood Banks) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 39: Global: Immunohematology (Diagnostic Laboratories) Market: Sales Value (in Million US$), 2015 & 2020
Figure 40: Global: Immunohematology (Diagnostic Laboratories) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 41: Global: Immunohematology (Other End-Users) Market: Sales Value (in Million US$), 2015 & 2020
Figure 42: Global: Immunohematology (Other End-Users) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 43: North America: Immunohematology Market: Sales Value (in Million US$), 2015 & 2020
Figure 44: North America: Immunohematology Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 45: United States: Immunohematology Market: Sales Value (in Million US$), 2015 & 2020
Figure 46: United States: Immunohematology Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 47: Canada: Immunohematology Market: Sales Value (in Million US$), 2015 & 2020
Figure 48: Canada: Immunohematology Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 49: Asia Pacific: Immunohematology Market: Sales Value (in Million US$), 2015 & 2020
Figure 50: Asia Pacific: Immunohematology Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 51: China: Immunohematology Market: Sales Value (in Million US$), 2015 & 2020
Figure 52: China: Immunohematology Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 53: Japan: Immunohematology Market: Sales Value (in Million US$), 2015 & 2020
Figure 54: Japan: Immunohematology Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 55: India: Immunohematology Market: Sales Value (in Million US$), 2015 & 2020
Figure 56: India: Immunohematology Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 57: South Korea: Immunohematology Market: Sales Value (in Million US$), 2015 & 2020
Figure 58: South Korea: Immunohematology Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 59: Australia: Immunohematology Market: Sales Value (in Million US$), 2015 & 2020
Figure 60: Australia: Immunohematology Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 61: Indonesia: Immunohematology Market: Sales Value (in Million US$), 2015 & 2020
Figure 62: Indonesia: Immunohematology Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 63: Others: Immunohematology Market: Sales Value (in Million US$), 2015 & 2020
Figure 64: Others: Immunohematology Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 65: Europe: Immunohematology Market: Sales Value (in Million US$), 2015 & 2020
Figure 66: Europe: Immunohematology Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 67: Germany: Immunohematology Market: Sales Value (in Million US$), 2015 & 2020
Figure 68: Germany: Immunohematology Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 69: France: Immunohematology Market: Sales Value (in Million US$), 2015 & 2020
Figure 70: France: Immunohematology Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 71: United Kingdom: Immunohematology Market: Sales Value (in Million US$), 2015 & 2020
Figure 72: United Kingdom: Immunohematology Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 73: Italy: Immunohematology Market: Sales Value (in Million US$), 2015 & 2020
Figure 74: Italy: Immunohematology Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 75: Spain: Immunohematology Market: Sales Value (in Million US$), 2015 & 2020
Figure 76: Spain: Immunohematology Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 77: Russia: Immunohematology Market: Sales Value (in Million US$), 2015 & 2020
Figure 78: Russia: Immunohematology Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 79: Others: Immunohematology Market: Sales Value (in Million US$), 2015 & 2020
Figure 80: Others: Immunohematology Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 81: Latin America: Immunohematology Market: Sales Value (in Million US$), 2015 & 2020
Figure 82: Latin America: Immunohematology Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 83: Brazil: Immunohematology Market: Sales Value (in Million US$), 2015 & 2020
Figure 84: Brazil: Immunohematology Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 85: Mexico: Immunohematology Market: Sales Value (in Million US$), 2015 & 2020
Figure 86: Mexico: Immunohematology Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 87: Others: Immunohematology Market: Sales Value (in Million US$), 2015 & 2020
Figure 88: Others: Immunohematology Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 89: Middle East and Africa: Immunohematology Market: Sales Value (in Million US$), 2015 & 2020
Figure 90: Middle East and Africa: Immunohematology Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 91: Global: Immunohematology Industry: SWOT Analysis
Figure 92: Global: Immunohematology Industry: Value Chain Analysis
Figure 93: Global: Immunohematology Industry: Porter’s Five Forces Analysis

List of Tables

Table 1: Global: Immunohematology Market: Key Industry Highlights, 2020 and 2026
Table 2: Global: Immunohematology Market Forecast: Breakup by Product (in Million US$), 2021-2026
Table 3: Global: Immunohematology Market Forecast: Breakup by Technology (in Million US$), 2021-2026
Table 4: Global: Immunohematology Market Forecast: Breakup by Application (in Million US$), 2021-2026
Table 5: Global: Immunohematology Market Forecast: Breakup by End-User (in Million US$), 2021-2026
Table 6: Global: Immunohematology Market Forecast: Breakup by Region (in Million US$), 2021-2026
Table 7: Global: Immunohematology Market: Competitive Structure
Table 8: Global: Immunohematology Market: Key Players

Note: We value your privacy and will never rent or sell your email address. Privacy policy

Need more help?

  •   Speak to our experienced analysts for insights on the current market scenarios.
  •   Include additional segments and countries to customize the report as per your requirement.
  •   Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  •   For further assistance, please connect with our analysts.

Purchase Options




$ 2299

REACH OUT TO US

Call us on

( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )


Drop us an email at

sales@imarcgroup.com

Social Links